You have free access to this content

British Journal of Clinical Pharmacology

Cover image for Vol. 80 Issue 4

Special Issue: Adverse Drug Reactions

October 2015

Volume 80, Issue 4

Pages i–iii, 611–926

  1. Issue Information

    1. Top of page
    2. Issue Information
    3. Issue Highlights
    4. Editors' View
    5. Commentary
    6. Therapeutics
    7. Pharmacokinetics
    8. Pharmacoepidemiology
    9. Drug Interactions
    10. Therapeutics
    11. Methods in Clinical Pharmacology
    12. Drug Safety
    13. Clinical Trials
    14. Drug Safety
    15. Drugs in Pregnancy and Lactation
    16. Methods in Clinical Pharmacology
    17. Pharmacoepidemiology
    18. New Drug Mechanisms
    19. Meta Analysis
    20. Letter to the Editor
    21. Themed Section - Adverse Drug Reactions
    22. Erratum
    1. You have free access to this content
      Issue Information (pages i–iii)

      Version of Record online: 27 SEP 2015 | DOI: 10.1111/bcp.12492

  2. Issue Highlights

    1. Top of page
    2. Issue Information
    3. Issue Highlights
    4. Editors' View
    5. Commentary
    6. Therapeutics
    7. Pharmacokinetics
    8. Pharmacoepidemiology
    9. Drug Interactions
    10. Therapeutics
    11. Methods in Clinical Pharmacology
    12. Drug Safety
    13. Clinical Trials
    14. Drug Safety
    15. Drugs in Pregnancy and Lactation
    16. Methods in Clinical Pharmacology
    17. Pharmacoepidemiology
    18. New Drug Mechanisms
    19. Meta Analysis
    20. Letter to the Editor
    21. Themed Section - Adverse Drug Reactions
    22. Erratum
    1. You have free access to this content
      Issue Highlights (pages 611–612)

      Version of Record online: 27 SEP 2015 | DOI: 10.1111/bcp.12782

  3. Editors' View

    1. Top of page
    2. Issue Information
    3. Issue Highlights
    4. Editors' View
    5. Commentary
    6. Therapeutics
    7. Pharmacokinetics
    8. Pharmacoepidemiology
    9. Drug Interactions
    10. Therapeutics
    11. Methods in Clinical Pharmacology
    12. Drug Safety
    13. Clinical Trials
    14. Drug Safety
    15. Drugs in Pregnancy and Lactation
    16. Methods in Clinical Pharmacology
    17. Pharmacoepidemiology
    18. New Drug Mechanisms
    19. Meta Analysis
    20. Letter to the Editor
    21. Themed Section - Adverse Drug Reactions
    22. Erratum
    1. You have free access to this content
      Adverse drug reactions (pages 613–614)

      Michael Rieder and Albert Ferro

      Version of Record online: 20 SEP 2015 | DOI: 10.1111/bcp.12695

  4. Commentary

    1. Top of page
    2. Issue Information
    3. Issue Highlights
    4. Editors' View
    5. Commentary
    6. Therapeutics
    7. Pharmacokinetics
    8. Pharmacoepidemiology
    9. Drug Interactions
    10. Therapeutics
    11. Methods in Clinical Pharmacology
    12. Drug Safety
    13. Clinical Trials
    14. Drug Safety
    15. Drugs in Pregnancy and Lactation
    16. Methods in Clinical Pharmacology
    17. Pharmacoepidemiology
    18. New Drug Mechanisms
    19. Meta Analysis
    20. Letter to the Editor
    21. Themed Section - Adverse Drug Reactions
    22. Erratum
    1. You have free access to this content
      Enhancing postmarketing surveillance: continuing challenges (pages 615–617)

      Dustin D. French, Curtis E. Margo and Robert R. Campbell

      Version of Record online: 1 JUN 2015 | DOI: 10.1111/bcp.12658

  5. Therapeutics

    1. Top of page
    2. Issue Information
    3. Issue Highlights
    4. Editors' View
    5. Commentary
    6. Therapeutics
    7. Pharmacokinetics
    8. Pharmacoepidemiology
    9. Drug Interactions
    10. Therapeutics
    11. Methods in Clinical Pharmacology
    12. Drug Safety
    13. Clinical Trials
    14. Drug Safety
    15. Drugs in Pregnancy and Lactation
    16. Methods in Clinical Pharmacology
    17. Pharmacoepidemiology
    18. New Drug Mechanisms
    19. Meta Analysis
    20. Letter to the Editor
    21. Themed Section - Adverse Drug Reactions
    22. Erratum
    1. You have free access to this content
      Busulfan dosing algorithm and sampling strategy in stem cell transplantation patients (pages 618–629)

      Francine A. de Castro, Chiara Piana, Belinda P. Simões, Vera L. Lanchote and O. Della Pasqua

      Version of Record online: 22 JUL 2015 | DOI: 10.1111/bcp.12648

      • image
      • image
      • image
      • image
      • image
  6. Pharmacokinetics

    1. Top of page
    2. Issue Information
    3. Issue Highlights
    4. Editors' View
    5. Commentary
    6. Therapeutics
    7. Pharmacokinetics
    8. Pharmacoepidemiology
    9. Drug Interactions
    10. Therapeutics
    11. Methods in Clinical Pharmacology
    12. Drug Safety
    13. Clinical Trials
    14. Drug Safety
    15. Drugs in Pregnancy and Lactation
    16. Methods in Clinical Pharmacology
    17. Pharmacoepidemiology
    18. New Drug Mechanisms
    19. Meta Analysis
    20. Letter to the Editor
    21. Themed Section - Adverse Drug Reactions
    22. Erratum
    1. You have free access to this content
      Population pharmacokinetic analysis of tacrolimus in Mexican paediatric renal transplant patients: role of CYP3A5 genotype and formulation (pages 630–641)

      Carlos Orlando Jacobo-Cabral, Pilar García-Roca, Elba Margarita Romero-Tejeda, Herlinda Reyes, Mara Medeiros, Gilberto Castañeda-Hernández and Iñaki F. Trocóniz

      Version of Record online: 22 JUN 2015 | DOI: 10.1111/bcp.12649

      • image
      • image
      • image
      • image
      • image
      • image
    2. You have full text access to this OnlineOpen article
      Opposite malaria and pregnancy effect on oral bioavailability of artesunate – a population pharmacokinetic evaluation (pages 642–653)

      Frank Kloprogge, Rose McGready, Aung Pyae Phyo, Marcus J. Rijken, Warunee Hanpithakpon, Hla Hla Than, Nathar Hlaing, Naw Thida Zin, Nicholas P. J. Day, Nicholas J. White, François Nosten and Joel Tarning

      Version of Record online: 22 JUL 2015 | DOI: 10.1111/bcp.12660

      • image
      • image
      • image
      • image
    3. You have free access to this content
      The pharmacokinetics and safety of darapladib in subjects with severe renal impairment (pages 654–661)

      Mindy He Magee, Bonnie Shaddinger, David Collins, Shabana Siddiqi and Joseph Soffer

      Version of Record online: 6 JUL 2015 | DOI: 10.1111/bcp.12661

      • image
  7. Pharmacoepidemiology

    1. Top of page
    2. Issue Information
    3. Issue Highlights
    4. Editors' View
    5. Commentary
    6. Therapeutics
    7. Pharmacokinetics
    8. Pharmacoepidemiology
    9. Drug Interactions
    10. Therapeutics
    11. Methods in Clinical Pharmacology
    12. Drug Safety
    13. Clinical Trials
    14. Drug Safety
    15. Drugs in Pregnancy and Lactation
    16. Methods in Clinical Pharmacology
    17. Pharmacoepidemiology
    18. New Drug Mechanisms
    19. Meta Analysis
    20. Letter to the Editor
    21. Themed Section - Adverse Drug Reactions
    22. Erratum
    1. You have full text access to this OnlineOpen article
      A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors (pages 662–669)

      Alex M. Cressman, Erin M. Macdonald, Kimberly A. Fernandes, Tara Gomes, J. Michael Paterson, Muhammad M. Mamdani and David N. Juurlink, for the Canadian Drug Safety Effectiveness Research Network (CDSERN)

      Version of Record online: 2 JUL 2015 | DOI: 10.1111/bcp.12682

      • image
  8. Drug Interactions

    1. Top of page
    2. Issue Information
    3. Issue Highlights
    4. Editors' View
    5. Commentary
    6. Therapeutics
    7. Pharmacokinetics
    8. Pharmacoepidemiology
    9. Drug Interactions
    10. Therapeutics
    11. Methods in Clinical Pharmacology
    12. Drug Safety
    13. Clinical Trials
    14. Drug Safety
    15. Drugs in Pregnancy and Lactation
    16. Methods in Clinical Pharmacology
    17. Pharmacoepidemiology
    18. New Drug Mechanisms
    19. Meta Analysis
    20. Letter to the Editor
    21. Themed Section - Adverse Drug Reactions
    22. Erratum
    1. You have free access to this content
      Effect of lopinavir/ritonavir on the pharmacokinetics of selexipag an oral prostacyclin receptor agonist and its active metabolite in healthy subjects (pages 670–677)

      Priska Kaufmann, Séverine Niglis, Shirin Bruderer, Jérôme Segrestaa, Päivi Äänismaa, Atef Halabi and Jasper Dingemanse

      Version of Record online: 12 JUN 2015 | DOI: 10.1111/bcp.12650

      • image
      • image
      • image
      • image
  9. Therapeutics

    1. Top of page
    2. Issue Information
    3. Issue Highlights
    4. Editors' View
    5. Commentary
    6. Therapeutics
    7. Pharmacokinetics
    8. Pharmacoepidemiology
    9. Drug Interactions
    10. Therapeutics
    11. Methods in Clinical Pharmacology
    12. Drug Safety
    13. Clinical Trials
    14. Drug Safety
    15. Drugs in Pregnancy and Lactation
    16. Methods in Clinical Pharmacology
    17. Pharmacoepidemiology
    18. New Drug Mechanisms
    19. Meta Analysis
    20. Letter to the Editor
    21. Themed Section - Adverse Drug Reactions
    22. Erratum
    1. You have free access to this content
      The renal protective effect of angiotensin receptor blockers depends on intra-individual response variation in multiple risk markers (pages 678–686)

      Bauke Schievink, Dick de Zeeuw, Hans-Henrik Parving, Peter Rossing and Hiddo Jan Lambers Heerspink

      Version of Record online: 28 MAY 2015 | DOI: 10.1111/bcp.12655

      • image
  10. Methods in Clinical Pharmacology

    1. Top of page
    2. Issue Information
    3. Issue Highlights
    4. Editors' View
    5. Commentary
    6. Therapeutics
    7. Pharmacokinetics
    8. Pharmacoepidemiology
    9. Drug Interactions
    10. Therapeutics
    11. Methods in Clinical Pharmacology
    12. Drug Safety
    13. Clinical Trials
    14. Drug Safety
    15. Drugs in Pregnancy and Lactation
    16. Methods in Clinical Pharmacology
    17. Pharmacoepidemiology
    18. New Drug Mechanisms
    19. Meta Analysis
    20. Letter to the Editor
    21. Themed Section - Adverse Drug Reactions
    22. Erratum
    1. You have free access to this content
      Development and validation of panoptic Meso scale discovery assay to quantify total systemic interleukin-6 (pages 687–697)

      Shalini Chaturvedi, Derick Siegel, Carrie L. Wagner, Jaehong Park, Helgi van de Velde, Jessica Vermeulen, Man-Cheong Fung, Manjula Reddy, Brett Hall and Kate Sasser

      Version of Record online: 4 JUN 2015 | DOI: 10.1111/bcp.12652

      • image
      • image
      • image
      • image
      • image
      • image
  11. Drug Safety

    1. Top of page
    2. Issue Information
    3. Issue Highlights
    4. Editors' View
    5. Commentary
    6. Therapeutics
    7. Pharmacokinetics
    8. Pharmacoepidemiology
    9. Drug Interactions
    10. Therapeutics
    11. Methods in Clinical Pharmacology
    12. Drug Safety
    13. Clinical Trials
    14. Drug Safety
    15. Drugs in Pregnancy and Lactation
    16. Methods in Clinical Pharmacology
    17. Pharmacoepidemiology
    18. New Drug Mechanisms
    19. Meta Analysis
    20. Letter to the Editor
    21. Themed Section - Adverse Drug Reactions
    22. Erratum
    1. You have free access to this content
      Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study (pages 698–705)

      Nevena M. Maljuric, Raymond Noordam, Nikkie Aarts, Maartje N. Niemeijer, Marten E. van den Berg, Albert Hofman, Jan A. Kors, Bruno H. Stricker and Loes E. Visser

      Version of Record online: 29 JUL 2015 | DOI: 10.1111/bcp.12681

  12. Clinical Trials

    1. Top of page
    2. Issue Information
    3. Issue Highlights
    4. Editors' View
    5. Commentary
    6. Therapeutics
    7. Pharmacokinetics
    8. Pharmacoepidemiology
    9. Drug Interactions
    10. Therapeutics
    11. Methods in Clinical Pharmacology
    12. Drug Safety
    13. Clinical Trials
    14. Drug Safety
    15. Drugs in Pregnancy and Lactation
    16. Methods in Clinical Pharmacology
    17. Pharmacoepidemiology
    18. New Drug Mechanisms
    19. Meta Analysis
    20. Letter to the Editor
    21. Themed Section - Adverse Drug Reactions
    22. Erratum
    1. You have full text access to this OnlineOpen article
      Evaluation of the QT effect of a combination of piperaquine and a novel anti-malarial drug candidate OZ439, for the treatment of uncomplicated malaria (pages 706–715)

      Borje Darpo, Georg Ferber, Peter Siegl, Bart Laurijssens, Fiona Macintyre, Stephen Toovey and Stephan Duparc

      Version of Record online: 14 JUL 2015 | DOI: 10.1111/bcp.12680

      • image
      • image
      • image
  13. Drug Safety

    1. Top of page
    2. Issue Information
    3. Issue Highlights
    4. Editors' View
    5. Commentary
    6. Therapeutics
    7. Pharmacokinetics
    8. Pharmacoepidemiology
    9. Drug Interactions
    10. Therapeutics
    11. Methods in Clinical Pharmacology
    12. Drug Safety
    13. Clinical Trials
    14. Drug Safety
    15. Drugs in Pregnancy and Lactation
    16. Methods in Clinical Pharmacology
    17. Pharmacoepidemiology
    18. New Drug Mechanisms
    19. Meta Analysis
    20. Letter to the Editor
    21. Themed Section - Adverse Drug Reactions
    22. Erratum
    1. You have free access to this content
      Regulatory review time and post-market safety events for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional study (pages 716–726)

      Jean-David Zeitoun, Jérémie H. Lefèvre, Nicholas S. Downing, Henri Bergeron and Joseph S. Ross

      Version of Record online: 28 MAY 2015 | DOI: 10.1111/bcp.12643

      • image
      • image
      • image
      • image
      • image
      • image
  14. Drugs in Pregnancy and Lactation

    1. Top of page
    2. Issue Information
    3. Issue Highlights
    4. Editors' View
    5. Commentary
    6. Therapeutics
    7. Pharmacokinetics
    8. Pharmacoepidemiology
    9. Drug Interactions
    10. Therapeutics
    11. Methods in Clinical Pharmacology
    12. Drug Safety
    13. Clinical Trials
    14. Drug Safety
    15. Drugs in Pregnancy and Lactation
    16. Methods in Clinical Pharmacology
    17. Pharmacoepidemiology
    18. New Drug Mechanisms
    19. Meta Analysis
    20. Letter to the Editor
    21. Themed Section - Adverse Drug Reactions
    22. Erratum
    1. You have free access to this content
      Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study (pages 727–739)

      Corinna Weber-Schoendorfer, Marc Oppermann, Evelin Wacker, Nathalie Bernard, on behalf of the network of French pharmacovigilance centres, Delphine Beghin, Benedikte Cuppers-Maarschalkerweerd, Jonathan L. Richardson, Laura E. Rothuizen, Alessandra Pistelli, Heli Malm, Georgios Eleftheriou, Debra Kennedy, Mine Kadioglu Duman, Reinhard Meister and Christof Schaefer

      Version of Record online: 28 MAY 2015 | DOI: 10.1111/bcp.12642

      • image
      • image
      • image
    2. You have full text access to this OnlineOpen article
      Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept study (pages 740–749)

      Steven Thornton, Hugh Miller, Guillermo Valenzuela, Jerry Snidow, Brendt Stier, Michael J. Fossler, Timothy H. Montague, Marcy Powell and Kathleen J. Beach

      Version of Record online: 1 JUN 2015 | DOI: 10.1111/bcp.12646

      • image
      • image
      • image
      • image
      • image
  15. Methods in Clinical Pharmacology

    1. Top of page
    2. Issue Information
    3. Issue Highlights
    4. Editors' View
    5. Commentary
    6. Therapeutics
    7. Pharmacokinetics
    8. Pharmacoepidemiology
    9. Drug Interactions
    10. Therapeutics
    11. Methods in Clinical Pharmacology
    12. Drug Safety
    13. Clinical Trials
    14. Drug Safety
    15. Drugs in Pregnancy and Lactation
    16. Methods in Clinical Pharmacology
    17. Pharmacoepidemiology
    18. New Drug Mechanisms
    19. Meta Analysis
    20. Letter to the Editor
    21. Themed Section - Adverse Drug Reactions
    22. Erratum
    1. You have free access to this content
      NSAIDs and spontaneous abortions – true effect or an indication bias? (pages 750–754)

      Sharon Daniel, Gideon Koren, Eitan Lunenfeld and Amalia Levy

      Version of Record online: 3 JUN 2015 | DOI: 10.1111/bcp.12653

      • image
  16. Pharmacoepidemiology

    1. Top of page
    2. Issue Information
    3. Issue Highlights
    4. Editors' View
    5. Commentary
    6. Therapeutics
    7. Pharmacokinetics
    8. Pharmacoepidemiology
    9. Drug Interactions
    10. Therapeutics
    11. Methods in Clinical Pharmacology
    12. Drug Safety
    13. Clinical Trials
    14. Drug Safety
    15. Drugs in Pregnancy and Lactation
    16. Methods in Clinical Pharmacology
    17. Pharmacoepidemiology
    18. New Drug Mechanisms
    19. Meta Analysis
    20. Letter to the Editor
    21. Themed Section - Adverse Drug Reactions
    22. Erratum
    1. You have free access to this content
      Statins are associated with a reduced risk of cholangiocarcinoma: a population-based case–control study (pages 755–761)

      Yen-Chun Peng, Cheng-Li Lin, Wan-Yun Hsu, Chi-Sen Chang, Hong-Zen Yeh, Chun-Fang Tung, Yuh-Lin Wu, Fung-Chang Sung and Chia-Hung Kao

      Version of Record online: 26 MAY 2015 | DOI: 10.1111/bcp.12641

      • image
  17. New Drug Mechanisms

    1. Top of page
    2. Issue Information
    3. Issue Highlights
    4. Editors' View
    5. Commentary
    6. Therapeutics
    7. Pharmacokinetics
    8. Pharmacoepidemiology
    9. Drug Interactions
    10. Therapeutics
    11. Methods in Clinical Pharmacology
    12. Drug Safety
    13. Clinical Trials
    14. Drug Safety
    15. Drugs in Pregnancy and Lactation
    16. Methods in Clinical Pharmacology
    17. Pharmacoepidemiology
    18. New Drug Mechanisms
    19. Meta Analysis
    20. Letter to the Editor
    21. Themed Section - Adverse Drug Reactions
    22. Erratum
    1. You have free access to this content
      Mirabegron (pages 762–764)

      Sebastiaan C. Goulooze, Adam F. Cohen and Robert Rissmann

      Version of Record online: 5 JUN 2015 | DOI: 10.1111/bcp.12647

      • image
    2. You have free access to this content
      Vemurafenib/dabrafenib and trametinib (pages 765–767)

      Robert Rissmann, Marleen H. M. Hessel and Adam F. Cohen

      Version of Record online: 11 JUN 2015 | DOI: 10.1111/bcp.12651

      • image
  18. Meta Analysis

    1. Top of page
    2. Issue Information
    3. Issue Highlights
    4. Editors' View
    5. Commentary
    6. Therapeutics
    7. Pharmacokinetics
    8. Pharmacoepidemiology
    9. Drug Interactions
    10. Therapeutics
    11. Methods in Clinical Pharmacology
    12. Drug Safety
    13. Clinical Trials
    14. Drug Safety
    15. Drugs in Pregnancy and Lactation
    16. Methods in Clinical Pharmacology
    17. Pharmacoepidemiology
    18. New Drug Mechanisms
    19. Meta Analysis
    20. Letter to the Editor
    21. Themed Section - Adverse Drug Reactions
    22. Erratum
    1. You have free access to this content
      The impact of pharmaceutical care interventions for medication underuse in older people: a systematic review and meta-analysis (pages 768–776)

      Andreas D. Meid, Anette Lampert, Alina Burnett, Hanna M. Seidling and Walter E. Haefeli

      Version of Record online: 12 JUN 2015 | DOI: 10.1111/bcp.12657

      • image
      • image
      • image
      • image
  19. Letter to the Editor

    1. Top of page
    2. Issue Information
    3. Issue Highlights
    4. Editors' View
    5. Commentary
    6. Therapeutics
    7. Pharmacokinetics
    8. Pharmacoepidemiology
    9. Drug Interactions
    10. Therapeutics
    11. Methods in Clinical Pharmacology
    12. Drug Safety
    13. Clinical Trials
    14. Drug Safety
    15. Drugs in Pregnancy and Lactation
    16. Methods in Clinical Pharmacology
    17. Pharmacoepidemiology
    18. New Drug Mechanisms
    19. Meta Analysis
    20. Letter to the Editor
    21. Themed Section - Adverse Drug Reactions
    22. Erratum
    1. You have free access to this content
    2. You have free access to this content
      Indication bias or protopathic bias? (pages 779–780)

      Jean-Luc Faillie

      Version of Record online: 16 SEP 2015 | DOI: 10.1111/bcp.12705

    3. You have free access to this content
      Reply to ‘Indication bias or protopathic bias?’ (page 781)

      Sharon Daniel, Gideon Koren, Eitan Lunenfeld and Amalia Levy

      Version of Record online: 16 SEP 2015 | DOI: 10.1111/bcp.12708

    4. You have free access to this content
      High metabolic N-oxidation of voriconazole in a patient with refractory aspergillosis and CYP2C19*17/*17 genotype (pages 782–784)

      Youssef Bennis, Sandra Bodeau, Régis Bouquié, Guillaume Deslandes, Céline Verstuyft, Bérangère Gruson, Michel Andréjak, Anne-Sophie Lemaire-Hurtel and Taieb Chouaki

      Version of Record online: 24 AUG 2015 | DOI: 10.1111/bcp.12713

      • image
  20. Themed Section - Adverse Drug Reactions

    1. Top of page
    2. Issue Information
    3. Issue Highlights
    4. Editors' View
    5. Commentary
    6. Therapeutics
    7. Pharmacokinetics
    8. Pharmacoepidemiology
    9. Drug Interactions
    10. Therapeutics
    11. Methods in Clinical Pharmacology
    12. Drug Safety
    13. Clinical Trials
    14. Drug Safety
    15. Drugs in Pregnancy and Lactation
    16. Methods in Clinical Pharmacology
    17. Pharmacoepidemiology
    18. New Drug Mechanisms
    19. Meta Analysis
    20. Letter to the Editor
    21. Themed Section - Adverse Drug Reactions
    22. Erratum
    1. You have free access to this content
      The burden of adverse drug events (pages 785–787)

      Alasdair Breckenridge

      Version of Record online: 1 JUN 2015 | DOI: 10.1111/bcp.12507

    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
      Number of drugs most frequently found to be independent risk factors for serious adverse reactions: a systematic literature review (pages 808–817)

      Eva A. Saedder, Marianne Lisby, Lars Peter Nielsen, Dorthe K. Bonnerup and Birgitte Brock

      Version of Record online: 19 MAY 2015 | DOI: 10.1111/bcp.12600

      • image
      • image
    5. You have free access to this content
      Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross-sectional survey (pages 818–826)

      Johannes P. Mouton, Ushma Mehta, Andy G. Parrish, Douglas P. K. Wilson, Annemie Stewart, Christine W. Njuguna, Nicole Kramer, Gary Maartens, Marc Blockman and Karen Cohen

      Version of Record online: 6 JUL 2015 | DOI: 10.1111/bcp.12567

      • figure
    6. You have free access to this content
      Quality of life in children with adverse drug reactions: a narrative and systematic review (pages 827–833)

      Blanca R. Del Pozzo-Magaña, Michael J. Rieder and Alejandro Lazo-Langner

      Version of Record online: 2 JUL 2015 | DOI: 10.1111/bcp.12423

      • figure
    7. You have free access to this content
      An overview on adverse drug reactions to traditional Chinese medicines (pages 834–843)

      Kelvin Chan, Hongwei Zhang and Zhi-Xiu Lin

      Version of Record online: 19 MAY 2015 | DOI: 10.1111/bcp.12598

    8. You have free access to this content
    9. You have free access to this content
      Adverse drug reactions – examples of detection of rare events using databases (pages 855–861)

      Esther W. Chan, Kirin Q. L. Liu, Celine S. L. Chui, Chor-Wing Sing, Lisa Y. L. Wong and Ian C. K. Wong

      Version of Record online: 1 JUN 2015 | DOI: 10.1111/bcp.12474

    10. You have free access to this content
    11. You have full text access to this OnlineOpen article
      Genotype-guided drug prescribing: a systematic review and meta-analysis of randomized control trials (pages 868–877)

      Rebecca Goulding, Diana Dawes, Morgan Price, Sabrina Wilkie and Martin Dawes

      Version of Record online: 22 JUL 2015 | DOI: 10.1111/bcp.12475

      • figure
      • figure
      • figure
      • figure
    12. You have free access to this content
    13. You have free access to this content
    14. You have free access to this content
      Drug-induced acute kidney injury in children (pages 901–909)

      Lauren N. Faught, Michael J. E. Greff, Michael J. Rieder and Gideon Koren

      Version of Record online: 1 JUN 2015 | DOI: 10.1111/bcp.12554

    15. You have free access to this content
      Social media and pharmacovigilance: A review of the opportunities and challenges (pages 910–920)

      Richard Sloane, Orod Osanlou, David Lewis, Danushka Bollegala, Simon Maskell and Munir Pirmohamed

      Version of Record online: 2 SEP 2015 | DOI: 10.1111/bcp.12717

      • image
      • image
  21. Erratum

    1. Top of page
    2. Issue Information
    3. Issue Highlights
    4. Editors' View
    5. Commentary
    6. Therapeutics
    7. Pharmacokinetics
    8. Pharmacoepidemiology
    9. Drug Interactions
    10. Therapeutics
    11. Methods in Clinical Pharmacology
    12. Drug Safety
    13. Clinical Trials
    14. Drug Safety
    15. Drugs in Pregnancy and Lactation
    16. Methods in Clinical Pharmacology
    17. Pharmacoepidemiology
    18. New Drug Mechanisms
    19. Meta Analysis
    20. Letter to the Editor
    21. Themed Section - Adverse Drug Reactions
    22. Erratum
    1. You have free access to this content

SEARCH

SEARCH BY CITATION